Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

8DEG

Crystal structure of DLK in complex with inhibitor DN0011197

Summary for 8DEG
Entry DOI10.2210/pdb8deg/pdb
DescriptorMitogen-activated protein kinase kinase kinase 12, methyl (1S,4S)-5-{(4P)-4-[5-amino-6-(difluoromethoxy)pyrazin-2-yl]-6-[(1R,4R)-2-azabicyclo[2.1.1]hexan-2-yl]pyridin-2-yl}-2,5-diazabicyclo[2.2.1]heptane-2-carboxylate (3 entities in total)
Functional Keywordsdlk, kinase, inhibitor, signaling protein, transferase-inhibitor complex, transferase/inhibitor
Biological sourceHomo sapiens (human)
Total number of polymer chains1
Total formula weight36883.27
Authors
Srivastava, A.,Lexa, K.,de Vicente, J. (deposition date: 2022-06-20, release date: 2022-12-14, Last modification date: 2024-04-03)
Primary citationCraig 2nd, R.A.,Fox, B.M.,Hu, C.,Lexa, K.W.,Osipov, M.,Thottumkara, A.P.,Larhammar, M.,Miyamoto, T.,Rana, A.,Kane, L.A.,Yulyaningsih, E.,Solanoy, H.,Nguyen, H.,Chau, R.,Earr, T.,Kajiwara, Y.,Fleck, D.,Lucas, A.,Haddick, P.C.G.,Takahashi, R.H.,Tong, V.,Wang, J.,Canet, M.J.,Poda, S.B.,Scearce-Levie, K.,Srivastava, A.,Sweeney, Z.K.,Xu, M.,Zhang, R.,He, J.,Lei, Y.,Zhuo, Z.,de Vicente, J.
Discovery of Potent and Selective Dual Leucine Zipper Kinase/Leucine Zipper-Bearing Kinase Inhibitors with Neuroprotective Properties in In Vitro and In Vivo Models of Amyotrophic Lateral Sclerosis.
J.Med.Chem., 65:16290-16312, 2022
Cited by
PubMed Abstract: Dual leucine zipper kinase (DLK) and leucine zipper-bearing kinase (LZK) are regulators of neuronal degeneration and axon growth. Therefore, there is a considerable interest in developing DLK/LZK inhibitors for neurodegenerative diseases. Herein, we use ligand- and structure-based drug design approaches for identifying novel amino-pyrazine inhibitors of DLK/LZK. DN-1289 (), a potent and selective dual DLK/LZK inhibitor, demonstrated excellent in vivo plasma half-life across species and is anticipated to freely penetrate the central nervous system with no brain impairment based on in vivo rodent pharmacokinetic studies and human in vitro transporter data. Proximal target engagement and disease relevant pathway biomarkers were also favorably regulated in an in vivo model of amyotrophic lateral sclerosis.
PubMed: 36469401
DOI: 10.1021/acs.jmedchem.2c01056
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.79 Å)
Structure validation

236963

PDB entries from 2025-06-04

PDB statisticsPDBj update infoContact PDBjnumon